🩸Facts about Multiple Myeloma:

Adverse Events and Management

#CRS #ICANS #Neurotoxicity #Neutropenia #Teclistamab #MajesTEC3 #Immunotherapy #Tocilizumab #Hematology #RareDiseases #BloodDisorders #ClinicalInsights #MedEd #HEMEHUB